维普期刊资源整合服务平台（V6.5）

352篇 您的检索式：作者名="Roehrborn"

选中清除导出查看参考文献查看引证文献引用追踪共18页首页上一页第1页下一页末页 /18 跳转

	题名	作者	年代	出处	被引量
1	Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses显示文摘	Yair Lotan Claus G Roehrborn	2003	Urology2003，，1：	2
2	The long-term effect of doxazosin finasteride,and combination therapy on the clinical progression of benign prostatic hyperplasia显示文摘	McConnell J D Roehrborn C G Bautisa O M	2003	N Engl Med2003，349，：	1
3	Efficacy and safety of dutasteride,tamsulosin and their combination in a subpopulation of the Comb AT study:2-year results in Asian men with moderateto-severe BPH显示文摘	Chung BH Roehrborn CG Siami P	2008	Prostate cancer and prostatic diseases2008，12，2：	1
4	Effect of dutasteride,a novel dual 5-alpha-reductase inhibitor,on BPH rdlated signs and symptoms显示文摘	Roehrborn CG Andriole G Nickel C	2002	J Urol2002，167，4：	1
5	The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia:4-year results from the CombAT study显示文摘	Roehrborn C G	2010	Eur Urol2010，57，：	1
6	Update on AUA guideline on the management of benign prostatic hyperplasia显示文摘	Mcvary K T Roehrborn C G Avins A L	2011	J Urol2011，185，5：	1
7	Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2(dutasteride) in men with benign prostatic hyperplasia显示文摘	Roehrborn Claus G Boyle Peter	2002	Urology2002，60，3：	1
8	Update on the Man- agement of benign prostatic Hyperplasia显示文摘	Mevary KT Roehrborn CG Avins AL	2011	J Urol2011，185，5：	1
9	Pre-operative per- cent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below lOng/ml 显示文摘	Shariat SF Abdel-Aziz KF Roehrborn CC	2006	Eur Urol2006，49，：	1
10	Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alphablocker treatment of patients with benign prostatic hyperplasia 显示文摘	Djavan B Roehrborn CG Shariat S	1999	JUrol1999，161，1：	1
11	Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater 显示文摘	Kaplan SA McConnell JD Roehrborn CG	2006	The Journal of Urology2006，175，21：	1
12	Management of ureteral calculi:a cost comparison and decision making analysis显示文摘	Lotan Y Gettman M T Roehrborn C G	2002	J Urol2002，167，4：	1
13	Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia显示文摘	Roehrborn Claus G Marks Leonard S Fenter Tom	2004	Urology2004，63，4：	1
14	Sensitivity and speci- ficity of commonly available bladder tumor markers versus cytology:results of a comprehensive literature review and meta-analyses显示文摘	LOTAN Y ROEHRBORN C G	2003	Urology2003，61，：	1
15	The long term effect of doxazosin,finasteride and combination ther- apy on the clinical progression of benign prostatic hyper- plasia显示文摘	McConnell JD Roehrborn CG Bautista OM	2003	N Engl J Med2003，349，25：	1
16	BPH progression:concept and key learning from MTOPS, ALTESS,COMBAT,and ALF-ONE显示文摘	Roehrborn CG	2008	BJU Int2008，101，3：	1
17	Acute urinary retention:risks and management 显示文摘	Roehrborn CG	2005	Rev Urol2005，7，4：	1
18	Benign prostatic hyperplasia显示文摘	Barry MJ Roehrborn CG	2001	BM2001，323，：	1
19	Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia显示文摘	ROEHRBORN C G BOYLE P NICKEL J C	2002	Urology2002，60，3：	1
20	Alpha(1)-Adrenergic Receptors and their Inhibitors in Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia 显示文摘	Roehrborn C G Schwinn D A	2004	J Urol2004，171，3：	1

返回顶部每页显示：

共18页首页上一页第1页下一页末页 /18 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示